New shot aims to stop the maddening itch of prurigo nodularis
NCT ID NCT06554509
First seen May 06, 2026 · Last updated May 21, 2026 · Updated 2 times
Summary
This study tests an experimental drug called SHR-1819, given as an injection, to see if it can safely reduce the intense itching caused by prurigo nodularis—a skin condition with hard, itchy bumps. About 423 adults will receive either the drug or a placebo, and researchers will track how much their itch scores drop over 16 to 24 weeks. The goal is to find a new option for people whose itching hasn't been controlled by other treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRURIGO NODULARIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University People's Hospital
RECRUITINGBeijing, Beijing Municipality, 100032, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.